These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35687862)

  • 1. Pregnancy Outcomes With Exposure to Second-Generation Antipsychotics During the First Trimester.
    Yakuwa N; Takahashi K; Anzai T; Ito N; Goto M; Koinuma S; Uno C; Suzuki T; Watanabe O; Yamatani A; Murashima A
    J Clin Psychiatry; 2022 Jun; 83(4):. PubMed ID: 35687862
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.
    McKenna K; Koren G; Tetelbaum M; Wilton L; Shakir S; Diav-Citrin O; Levinson A; Zipursky RB; Einarson A
    J Clin Psychiatry; 2005 Apr; 66(4):444-9; quiz 546. PubMed ID: 15816786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
    Djulus J; Koren G; Einarson TR; Wilton L; Shakir S; Diav-Citrin O; Kennedy D; Voyer Lavigne S; De Santis M; Einarson A
    J Clin Psychiatry; 2006 Aug; 67(8):1280-4. PubMed ID: 16965209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy Outcomes Following In Utero Exposure to Second-Generation Antipsychotics: A Systematic Review and Meta-Analysis.
    Terrana N; Koren G; Pivovarov J; Etwel F; Nulman I
    J Clin Psychopharmacol; 2015 Oct; 35(5):559-65. PubMed ID: 26274044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study.
    Habermann F; Fritzsche J; Fuhlbrück F; Wacker E; Allignol A; Weber-Schoendorfer C; Meister R; Schaefer C
    J Clin Psychopharmacol; 2013 Aug; 33(4):453-62. PubMed ID: 23764684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
    Huybrechts KF; Hernández-Díaz S; Patorno E; Desai RJ; Mogun H; Dejene SZ; Cohen JM; Panchaud A; Cohen L; Bateman BT
    JAMA Psychiatry; 2016 Sep; 73(9):938-46. PubMed ID: 27540849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Cohen LS; Viguera AC; McInerney KA; Freeman MP; Sosinsky AZ; Moustafa D; Marfurt SP; Kwiatkowski MA; Murphy SK; Farrell AM; Chitayat D; Hernández-Díaz S
    Am J Psychiatry; 2016 Mar; 173(3):263-70. PubMed ID: 26441156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Viguera AC; Freeman MP; Góez-Mogollón L; Sosinsky AZ; McElheny SA; Church TR; Young AV; Caplin PS; Chitayat D; Hernández-Díaz S; Cohen LS
    J Clin Psychiatry; 2021 Aug; 82(4):. PubMed ID: 34352165
    [No Abstract]   [Full Text] [Related]  

  • 9. Maternal antipsychotic use during pregnancy and congenital malformations.
    Liu X; Kolding L; Momen N; Gasse C; Pedersen LH
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100950. PubMed ID: 37015311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study.
    Chuang CH; Doyle P; Wang JD; Chang PJ; Lai JN; Chen PC
    Drug Saf; 2006; 29(6):537-48. PubMed ID: 16752935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major Congenital Malformations Associated With Exposure to Second-Generation Antipsychotic Drugs During Pregnancy.
    Andrade C
    J Clin Psychiatry; 2021 Oct; 82(5):. PubMed ID: 34610230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.
    Coppola D; Russo LJ; Kwarta RF; Varughese R; Schmider J
    Drug Saf; 2007; 30(3):247-64. PubMed ID: 17343431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine.
    Cohen LS; Góez-Mogollón L; Sosinsky AZ; Savella GM; Viguera AC; Chitayat D; Hernández-Díaz S; Freeman MP
    Am J Psychiatry; 2018 Dec; 175(12):1225-1231. PubMed ID: 30111186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir.
    Vannappagari V; Thorne C;
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):371-378. PubMed ID: 30939532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.
    Einarson A; Fatoye B; Sarkar M; Lavigne SV; Brochu J; Chambers C; Mastroiacovo P; Addis A; Matsui D; Schuler L; Einarson TR; Koren G
    Am J Psychiatry; 2001 Oct; 158(10):1728-30. PubMed ID: 11579012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes.
    Bérard A; Zhao JP; Shui I; Colilla S
    Ann Rheum Dis; 2018 Apr; 77(4):500-509. PubMed ID: 29222350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis.
    Kaplan YC; Ozsarfati J; Etwel F; Nickel C; Nulman I; Koren G
    Br J Dermatol; 2015 Nov; 173(5):1132-41. PubMed ID: 26215715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies.
    Bérard A; Sheehy O; Zhao JP; Gorgui J; Bernatsky S; de Moura CS; Abrahamowicz M
    CMAJ; 2019 Feb; 191(7):E179-E187. PubMed ID: 30782643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid monotherapy in pregnancy and major congenital malformations.
    Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
    N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes.
    Bérard A; Sheehy O; Kurzinger ML; Juhaeri J
    J Allergy Clin Immunol; 2016 Jul; 138(1):97-104.e7. PubMed ID: 27045580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.